Takeda Pharmaceutical (TAK) FCF Payout Ratio Growth (5y) (2023 - 2026)
Takeda Pharmaceutical (TAK) FCF Payout Ratio Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.28% |
| Dec 31, 2025 | 8.10% |
| Sep 30, 2025 | 7.84% |
| Jun 30, 2025 | 6.87% |
| Mar 31, 2025 | 10.27% |
| Sep 30, 2024 | -11.96% |
| Jun 30, 2024 | 7.20% |
| Mar 31, 2024 | 11.86% |
| Dec 31, 2023 | -3.36% |
| Sep 30, 2023 | 10.89% |
| Jun 30, 2023 | 2.66% |
| Mar 31, 2023 | 10.43% |